Thus, the study of individualized TREM2 modulation in monocyte-derived macrophages (Mo-MФs) as a functional proxy for brain infiltrating macrophages in AD could offer insights into possible personalized therapeutic approaches (Cosma et al. 2021). This evidence concerns the gene TREM2 and Alzheimer disease.